TR
EN
Chemotherapy Side Effects and Youtube Platform; What do Patients Watch?
Öz
Objective: This study was aimed to evaluate the content, quantity and reliability of YouTube videos in which the side effects of chemotherapy are explained in a country sample.
Materials and Methods: It was searched in the search bar on YouTubeTM on 29 August 2022 using the keyword 'chemotherapy side effects'. 55 videos between 0-20 min were evaluated simultaneously by 3 independent experts using the Quality Criteria for Consumer Health Information (DISCERN) scale and the Global Quality Scale (GQS).
Results: The three most common uploader profiles were physician, patient and health-related website. The most of contents of the videos consisted of general chemotherapy and side effects, patient experiences. The DISCERN score average was 56, and the GQS was 3.00. When the scores of the video uploaders were compared, it was found that there was no significant difference between the scores of DISCERN (p=0.245) and GQS (p=0.647). There was a significant difference between the groups in the video duration, the number of likes and comments, and the rate of comments (p=0.001, 0.049, 0.004, 0.003, respectively).
Conclusion: As a result, the quality of the information in the videos is good and the educational value is moderate. It has been determined that the videos uploaded by the patients are watched more, receive more likes and are viewed more frequently.
Anahtar Kelimeler
Kaynakça
- Alexa. (2022). The top 500 sites on the web. Retrieved from https://www.alexa.com/topsites Auxier, B., & Anderson, M. (2021). Social media use in 2021. Pew Research Center. Retrieved from https://www.pewresearch.org/internet/2021/04/07/social-media-use-in-2021/
- Azer, S. A. (2020). Are DISCERN and JAMA suitable instruments for assessing YouTube videos on thyroid cancer? Journal of Cancer Education, 35, 1267–127. https://doi.org/10.1007/s13187-020
- Behranvand, N., Nasri, F., Zolfaghari Emameh, R., Khani, P., Hosseini, A., Garssen, J., & Falak, R. (2022). Chemotherapy: A double-edged sword in cancer treatment. Cancer Immunology, Immunotherapy, 71(3), 507-526. https://doi.org/10.1007/s00262-021-03013-3
- Bernard, A., Langille, M., Hughes, S., Rose, C., Leddin, D., & Veldhuyzen van Zanten, S. A. (2007). A systematic review of patient inflammatory bowel disease information resources on the World Wide Web. The American Journal of Gastroenterology, 102(9), 2070-2077. https://doi.org/10.1111/j.1572-0241.2007.01325.x
- Biggs, T. C., Bird, J. H., Harries, P. G., & Salib, R. J. (2013). YouTube as a source of information on rhinosinusitis: The good, the bad and the ugly. The Journal of Laryngology & Otology, 127(8), 749-754. https://doi.org/10.1017/S0022215113001473
- Coolbrandt, A., Dierckx de Casterlé, B., Wildiers, H., Aertgeerts, B., Van der Elst, E., van Achterberg, T., & Milisen, K. (2016). Dealing with chemotherapy-related symptoms at home: A qualitative study in adult patients with cancer. European Journal of Cancer Care (Engl), 25(1), 79-92. https://doi.org/10.1111/ecc.12303
- Dadkhah, M., Mehraeen, M., Rahimnia, F., & Kimiafar, K. (2021). Use of Internet of Things for chronic disease management: An overview. Journal of Medical Signals and Sensors, 24(2), 138-157. https://doi.org/10.4103/jmss.JMSS_13_20
- DISCERN—General instructions. (n.d.). Retrieved September 2, 2022, from www.discern.org.uk Guo, P., Kim, J., & Rubin, R. (2014). How video production affects student engagement: An empirical study of MOOC videos. In Proceedings of the first ACM conference on Learning at scale conference (pp. 41-50). https://doi.org/10.1145/2556325.2566239
Ayrıntılar
Birincil Dil
İngilizce
Konular
Dahili Hastalıklar Hemşireliği, Sağlık Hizmetleri ve Sistemleri (Diğer)
Bölüm
Araştırma Makalesi
Yayımlanma Tarihi
30 Nisan 2025
Gönderilme Tarihi
12 Şubat 2025
Kabul Tarihi
16 Mart 2025
Yayımlandığı Sayı
Yıl 2025 Cilt: 6 Sayı: 1
APA
Bektaş Akpınar, N., Özcan Yüce, U., Gumus, A. P. C., Sezerer Albayrak, E., & Mallı, E. (2025). Chemotherapy Side Effects and Youtube Platform; What do Patients Watch? KTO Karatay Üniversitesi Sağlık Bilimleri Dergisi, 6(1), 110-121. https://doi.org/10.59244/ktokusbd.1638485
AMA
1.Bektaş Akpınar N, Özcan Yüce U, Gumus APC, Sezerer Albayrak E, Mallı E. Chemotherapy Side Effects and Youtube Platform; What do Patients Watch? KTOKUSB-D. 2025;6(1):110-121. doi:10.59244/ktokusbd.1638485
Chicago
Bektaş Akpınar, Nilay, Ulviye Özcan Yüce, Assoc. Prof. Cagrı Gumus, Eda Sezerer Albayrak, ve Esen Mallı. 2025. “Chemotherapy Side Effects and Youtube Platform; What do Patients Watch?”. KTO Karatay Üniversitesi Sağlık Bilimleri Dergisi 6 (1): 110-21. https://doi.org/10.59244/ktokusbd.1638485.
EndNote
Bektaş Akpınar N, Özcan Yüce U, Gumus APC, Sezerer Albayrak E, Mallı E (01 Nisan 2025) Chemotherapy Side Effects and Youtube Platform; What do Patients Watch? KTO Karatay Üniversitesi Sağlık Bilimleri Dergisi 6 1 110–121.
IEEE
[1]N. Bektaş Akpınar, U. Özcan Yüce, A. P. C. Gumus, E. Sezerer Albayrak, ve E. Mallı, “Chemotherapy Side Effects and Youtube Platform; What do Patients Watch?”, KTOKUSB-D, c. 6, sy 1, ss. 110–121, Nis. 2025, doi: 10.59244/ktokusbd.1638485.
ISNAD
Bektaş Akpınar, Nilay - Özcan Yüce, Ulviye - Gumus, Assoc. Prof. Cagrı - Sezerer Albayrak, Eda - Mallı, Esen. “Chemotherapy Side Effects and Youtube Platform; What do Patients Watch?”. KTO Karatay Üniversitesi Sağlık Bilimleri Dergisi 6/1 (01 Nisan 2025): 110-121. https://doi.org/10.59244/ktokusbd.1638485.
JAMA
1.Bektaş Akpınar N, Özcan Yüce U, Gumus APC, Sezerer Albayrak E, Mallı E. Chemotherapy Side Effects and Youtube Platform; What do Patients Watch? KTOKUSB-D. 2025;6:110–121.
MLA
Bektaş Akpınar, Nilay, vd. “Chemotherapy Side Effects and Youtube Platform; What do Patients Watch?”. KTO Karatay Üniversitesi Sağlık Bilimleri Dergisi, c. 6, sy 1, Nisan 2025, ss. 110-21, doi:10.59244/ktokusbd.1638485.
Vancouver
1.Nilay Bektaş Akpınar, Ulviye Özcan Yüce, Assoc. Prof. Cagrı Gumus, Eda Sezerer Albayrak, Esen Mallı. Chemotherapy Side Effects and Youtube Platform; What do Patients Watch? KTOKUSB-D. 01 Nisan 2025;6(1):110-21. doi:10.59244/ktokusbd.1638485